Vivera Pharmaceuticals Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vivera Pharmaceuticals Inc..The latest application filed is for "sublingual delivery for mitigation of side effects associated with metformin".

Company Profile

10.8.24

Vivera Pharmaceuticals Inc. - Newport Beach CA
Vivera Pharmaceuticals Inc. - Las Vegas NV US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Secure smart dosing system with automated delivery, measurement, and management for pills Grant 11,450,420 - Hatamian , et al. September 20, 2	2022-09-20
Self-contained, portable, sanitization device and telemedicine station Grant 11,406,728 - Hatamian , et al. August 9, 2	2022-08-09
Sublingual Delivery For Mitigation Of Side Effects Associated With Metformin App 20220168226 - Edalat; Paul ; et al.	2022-06-02
Sublingual Delivery For Mitigation Of Side Effects Associated With Vortioxetine App 20220117900 - Edalat; Paul ; et al.	2022-04-21
Sublingual Delivery For Mitigation Of Side Effects Associated With Brexpiprazole App 20220117901 - Edalat; Paul ; et al.	2022-04-21
Self-Contained, Portable, Sanitization Device and Telemedicine Station App 20220111091 - Hatamian; Mehdi ; et al.	2022-04-14
Sublingual Delivery For Mitigation Of Side Effects Associated With Lurasidone App 20220096387 - Edalat; Paul ; et al.	2022-03-31
Sublingual Delivery for Mitigation of Side Effects Associated with Sildenafil Citrate App 20220062189 - Edalat; Paul ; et al.	2022-03-03
Sublingual Delivery For Mitigation Of Side Effects Associated With Blonanserin App 20220023223 - Edalat; Paul ; et al.	2022-01-27
Sublingual Delivery For Mitigation Of Side Effects Associated With Olanzapine And Metformin App 20210401757 - Edalat; Paul ; et al.	2021-12-30
Sublingual Delivery For Mitigation Of Side Effects Associated With Trazodone App 20210401758 - Edalat; Paul ; et al.	2021-12-30
Secure Smart Dosing System With Automated Delivery, Measurement, And Management For Pills App 20210366589 - Hatamian; Mehdi ; et al.	2021-11-25
Self-administered Infection Testing And Result Determination App 20210311056 - Edalat; Paul ; et al.	2021-10-07
Smart inhaler device with automated dose delivery, measurement, and management Grant 11,090,449 - Hatamian , et al. August 17, 2	2021-08-17
Secure smart dosing system with automated delivery, measurement, and management Grant 11,083,850 - Hatamian , et al. August 10, 2	2021-08-10
Smart Inhaler Device With Automated Dose Delivery, Measurement, And Management App 20200061314 - Hatamian; Mehdi ; et al.	2020-02-27
Secure Smart Dosing System With Automated Delivery, Measurement, And Management App 20200061301 - Hatamian; Mehdi ; et al.	2020-02-27

Company Registrations

SEC

0001751371

Vivera Pharmaceuticals, Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.